Early Evidence of Impact of Monovalent Rotavirus Vaccine in Togo.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 27059356.
- Also identified by DOI 10.1093/cid/civ1182.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Togo introduced monovalent rotavirus vaccine starting 19 June 2014. We compared all-cause acute gastroenteritis (AGE) hospitalizations and rotavirus-associated hospitalizations during the prevaccine period (July 2008-June 2014) to 1 year after vaccine introduction (July 2014-June 2015). The proportion of children with AGE who tested positive for rotavirus declined from 53% (645/1223) in prevaccine years to 36% (68/187) in the postvaccine year (P< .01). The decline only occurred in children <1 year of age who were eligible for vaccination and was greatest during the rotavirus season months, supporting that it was associated with vaccine implementation.
Medical subject headings
- Gastroenteritis
- Rotavirus Infections
- Rotavirus Vaccines
- Vaccination